Drug level in human liver microsomes treated with [14C]-rivoglitazone at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UD...

Basic Information

ID: ALA3540219

Type: ADME

Description: Drug level in human liver microsomes treated with [14C]-rivoglitazone at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM

Format: BAO_0000019

Organism: Homo sapiens

Tissue: Liver

Target: Liver microsome(ALA2367379)

Document: ALA3526048

Drug level in human liver microsomes treated with [14C]-rivoglitazone at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA3540219

Drug metabolism

Total(2)

Parent Molecular Weight	ALogP	Polar Surface Area
591.60	0.49	0.49
573.58	0.66	0.66

Parent Molecular Weight

ALogP

Polar Surface Area

591.60

0.49

573.58

0.66

Drug level in human liver microsomes treated with [14C]-rivoglitazone at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UD...

Basic Information

Activity Charts

Compound Summary